Increased tissue histamine in tumour-bearing mice and rats. 1981

C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu

Tissue histamine levels were studied in C3H and C57BL/6 mice bearing a methylcholanthrene-induced fibrosarcoma, in Wag rats bearing an aflatoxin B1-induced hepatoma, and in Commentry rats bearing a grafted hepatoma. Histamine levels were significantly higher (1.5 to 3 fold) in the tumour-bearing animals for ventral and dorsal skin, skeletal muscle and stomach fundus. Total histamine content was increased in the spleen. In C3H mice with McC3-1 fibrosarcoma, the excision of the tumour or its partial regression by intratumoral injections of corynebacterium parvum induced a reversion to normal values. The tumour thus appears responsible for the increased histamine levels in tissues distant from the tumour.

UI MeSH Term Description Entries
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D006632 Histamine An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter. Ceplene,Histamine Dihydrochloride,Histamine Hydrochloride,Peremin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012513 Sarcoma, Experimental Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA. EHS Tumor,Sarcoma, Engelbreth-Holm-Swarm,Sarcoma, Jensen,Experimental Sarcoma,Experimental Sarcomas,Sarcomas, Experimental,Engelbreth-Holm-Swarm Sarcoma,Jensen Sarcoma,Sarcoma, Engelbreth Holm Swarm,Tumor, EHS
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
November 2011, Placenta,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
March 1966, Nature,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
April 1999, International journal of experimental pathology,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
April 1994, The Biochemical journal,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
January 1998, Cancer chemotherapy and pharmacology,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
August 1995, Journal of photochemistry and photobiology. B, Biology,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
February 1994, FEBS letters,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
September 1966, Life sciences,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
April 1984, Agents and actions,
C Burtin, and P Scheinmann, and J C Salomon, and G Lespinats, and C Frayssinet, and B Lebel, and P Canu
April 1996, Biochemical and biophysical research communications,
Copied contents to your clipboard!